Nanotherapeutics Company Overview

Nanotherapeutics has significant expertise in product formulation, pre-clinical and clinical development, scale-up and cGMP manufacturing, utilizing established and proprietary techniques: NanoQUAD™, NanoDRY™, and NanoCOAT™. Our specialized proprietary techniques can improve the release rate and enhance both the rate and extent of drug uptake, thus increasing bioavailability. The consequences of these changes include more consistent drug therapy with potentially reduced dose and dose frequency requirements and fewer side effects.

Our specialized technologies, proprietary processing techniques and know-how set us apart from most other biopharmaceutical companies. Key pharmaceutical advantages of our technologies include:

• Broad applicability - Our delivery options are applicable to a diverse group of drug molecules - proteins, peptides and other poorly absorbed compounds.
  
  

• Versatility of formulation - We have created various types of injectable, inhaled and oral formulations using our particle-based delivery expertise.
  
  

• Stabilization - We have demonstrated more than twelve months of room temperature stability with different formulations - including proteins - without loss of activity or dispersability.
  
  

• Ease of Manufacture - Scale-up to commercial quantities of production is readily obtainable at cost-effective levels.